| Dr John M Dobrowski, MD | |
|
243 Charles St, Boston, MA 02114-3002 | |
| (617) 573-4104 | |
| (617) 573-3914 |
| Full Name | Dr John M Dobrowski |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 45 Years |
| Location | 243 Charles St, Boston, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538160452 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 252443 (Massachusetts) | Primary |
| 207YS0012X | Otolaryngology - Sleep Medicine | 252443 (Massachusetts) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Massachusetts Eye And Ear Infirmary - | Boston, MA | Hospital |
| Massachusetts General Hospital | Boston, MA | Hospital |
| Brigham And Women's Hospital | Boston, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Massachusetts Eye And Ear Associates, Inc | 4486540275 | 337 |
| Massachusetts General Physicians Organization Inc | 2466365820 | 3085 |
News Archive
The way in which heart and lung transplant recipients acquired a specific species of bacteria, Mycoplasma hominis, had been previously undefined, and the bacterium was difficult to test.
Oculus Innovative Sciences, Inc., a commercial medical technology company that designs, produces and markets safe and effective tissue care products based upon the Microcyn® Technology platform, today introduced the Microcyn Negative-Pressure Wound Therapy Solution™ for the U.S. professional healthcare market. Within the pH ranges of 6-7.8 desired for optimum negative-pressure wound therapy, Microcyn is intended for the irrigation and management of wounds via these advanced systems.
Methotrexate (MTX) is commonly used to treat rheumatoid arthritis (RA) and is suggested as the "anchor" drug in treating the disease.
The Global Fund to Fight AIDS, Tuberculosis and Malaria awarded Nigeria a $669 million Round 8 grant for health system strengthening over five years, This Day/allAfrica.com reports. "During the grant signing ceremony in Abuja yesterday, Chairman of the occasion and former Head of State, General Yakubu Gowon, disclosed that the [The Global Fund] had spent $15.6 billion in 140 countries worldwide especially in Africa to support large scale prevention treatment and care programmes against these diseases.
› Verified 2 days ago
| Entity Name | Massachusetts General Physicians Organization Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801874573 PECOS PAC ID: 2466365820 Enrollment ID: O20031111000434 |
News Archive
The way in which heart and lung transplant recipients acquired a specific species of bacteria, Mycoplasma hominis, had been previously undefined, and the bacterium was difficult to test.
Oculus Innovative Sciences, Inc., a commercial medical technology company that designs, produces and markets safe and effective tissue care products based upon the Microcyn® Technology platform, today introduced the Microcyn Negative-Pressure Wound Therapy Solution™ for the U.S. professional healthcare market. Within the pH ranges of 6-7.8 desired for optimum negative-pressure wound therapy, Microcyn is intended for the irrigation and management of wounds via these advanced systems.
Methotrexate (MTX) is commonly used to treat rheumatoid arthritis (RA) and is suggested as the "anchor" drug in treating the disease.
The Global Fund to Fight AIDS, Tuberculosis and Malaria awarded Nigeria a $669 million Round 8 grant for health system strengthening over five years, This Day/allAfrica.com reports. "During the grant signing ceremony in Abuja yesterday, Chairman of the occasion and former Head of State, General Yakubu Gowon, disclosed that the [The Global Fund] had spent $15.6 billion in 140 countries worldwide especially in Africa to support large scale prevention treatment and care programmes against these diseases.
› Verified 2 days ago
| Entity Name | Massachusetts Eye And Ear Associates, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932574332 PECOS PAC ID: 4486540275 Enrollment ID: O20040227000123 |
News Archive
The way in which heart and lung transplant recipients acquired a specific species of bacteria, Mycoplasma hominis, had been previously undefined, and the bacterium was difficult to test.
Oculus Innovative Sciences, Inc., a commercial medical technology company that designs, produces and markets safe and effective tissue care products based upon the Microcyn® Technology platform, today introduced the Microcyn Negative-Pressure Wound Therapy Solution™ for the U.S. professional healthcare market. Within the pH ranges of 6-7.8 desired for optimum negative-pressure wound therapy, Microcyn is intended for the irrigation and management of wounds via these advanced systems.
Methotrexate (MTX) is commonly used to treat rheumatoid arthritis (RA) and is suggested as the "anchor" drug in treating the disease.
The Global Fund to Fight AIDS, Tuberculosis and Malaria awarded Nigeria a $669 million Round 8 grant for health system strengthening over five years, This Day/allAfrica.com reports. "During the grant signing ceremony in Abuja yesterday, Chairman of the occasion and former Head of State, General Yakubu Gowon, disclosed that the [The Global Fund] had spent $15.6 billion in 140 countries worldwide especially in Africa to support large scale prevention treatment and care programmes against these diseases.
› Verified 2 days ago
| Entity Name | The General Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023049236 PECOS PAC ID: 6507803806 Enrollment ID: O20080313000351 |
News Archive
The way in which heart and lung transplant recipients acquired a specific species of bacteria, Mycoplasma hominis, had been previously undefined, and the bacterium was difficult to test.
Oculus Innovative Sciences, Inc., a commercial medical technology company that designs, produces and markets safe and effective tissue care products based upon the Microcyn® Technology platform, today introduced the Microcyn Negative-Pressure Wound Therapy Solution™ for the U.S. professional healthcare market. Within the pH ranges of 6-7.8 desired for optimum negative-pressure wound therapy, Microcyn is intended for the irrigation and management of wounds via these advanced systems.
Methotrexate (MTX) is commonly used to treat rheumatoid arthritis (RA) and is suggested as the "anchor" drug in treating the disease.
The Global Fund to Fight AIDS, Tuberculosis and Malaria awarded Nigeria a $669 million Round 8 grant for health system strengthening over five years, This Day/allAfrica.com reports. "During the grant signing ceremony in Abuja yesterday, Chairman of the occasion and former Head of State, General Yakubu Gowon, disclosed that the [The Global Fund] had spent $15.6 billion in 140 countries worldwide especially in Africa to support large scale prevention treatment and care programmes against these diseases.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John M Dobrowski, MD 243 Charles St, Boston, MA 02114-3002 Ph: (617) 573-4104 | Dr John M Dobrowski, MD 243 Charles St, Boston, MA 02114-3002 Ph: (617) 573-4104 |
News Archive
The way in which heart and lung transplant recipients acquired a specific species of bacteria, Mycoplasma hominis, had been previously undefined, and the bacterium was difficult to test.
Oculus Innovative Sciences, Inc., a commercial medical technology company that designs, produces and markets safe and effective tissue care products based upon the Microcyn® Technology platform, today introduced the Microcyn Negative-Pressure Wound Therapy Solution™ for the U.S. professional healthcare market. Within the pH ranges of 6-7.8 desired for optimum negative-pressure wound therapy, Microcyn is intended for the irrigation and management of wounds via these advanced systems.
Methotrexate (MTX) is commonly used to treat rheumatoid arthritis (RA) and is suggested as the "anchor" drug in treating the disease.
The Global Fund to Fight AIDS, Tuberculosis and Malaria awarded Nigeria a $669 million Round 8 grant for health system strengthening over five years, This Day/allAfrica.com reports. "During the grant signing ceremony in Abuja yesterday, Chairman of the occasion and former Head of State, General Yakubu Gowon, disclosed that the [The Global Fund] had spent $15.6 billion in 140 countries worldwide especially in Africa to support large scale prevention treatment and care programmes against these diseases.
› Verified 2 days ago
Dr. Steven D. Rauch, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 243 Charles St, Boston, MA 02114 Phone: 617-523-7900 | |
Elliott D. Kozin, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 243 Charles St, Boston, MA 02114 Phone: 617-573-6545 | |
Katherine Nicole Vandenberg, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 830 Harrison Ave Ste 1400, Boston, MA 02118 Phone: 617-638-8124 | |
Yoon Sun Chun, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 75 Francis St, Brigham And Women's Hospital Dept Of Plastic Surgery, Boston, MA 02115 Phone: 617-732-8181 Fax: 617-983-4534 | |
Jaimie Derosa, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 91 Newbury St, Suite 300, Boston, MA 02116 Phone: 617-262-8000 Fax: 617-262-8002 | |
Dr. Usama M Aboelkheir, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 736 Cambridge St, Smc8, Boston, MA 02135 Phone: 617-789-5004 Fax: 617-779-6481 | |
Phillip C Song, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 243 Charles St, Boston, MA 02114 Phone: 617-573-3557 |